Boston Family Office’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,274
| Closed | -$295K | – | 277 |
|
|
2022
Q1 | $295K | Buy |
11,274
+250
| +2% | +$6.54K | 0.02% | 245 |
|
|
2021
Q4 | $437K | Buy |
11,024
+4,633
| +72% | +$184K | 0.03% | 222 |
|
|
2021
Q3 | $320K | Buy |
6,391
+1,289
| +25% | +$64.5K | 0.02% | 238 |
|
|
2021
Q2 | $283K | Buy |
+5,102
| New | +$283K | 0.02% | 245 |
|